4,997 Shares of Kimberly-Clark Corporation $KMB Acquired by Burns Matteson Capital Management LLC

Burns Matteson Capital Management LLC acquired a new position in shares of Kimberly-Clark Corporation (NASDAQ:KMB – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,997 shares of the company’s stock, valued at approximately $487,000.

Other large investors also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of Kimberly-Clark in the 2nd quarter valued at approximately $3,547,915,000. Thornburg Investment Management Inc. acquired a new position in Kimberly-Clark during the second quarter worth $632,373,000. Bank of New York Mellon Corp acquired a new position in Kimberly-Clark during the second quarter worth $239,612,000. Legal & General Group Plc acquired a new position in Kimberly-Clark during the second quarter worth $223,668,000. Finally, Diamond Hill Capital Management LLC Investment Advisor bought a new stake in Kimberly-Clark during the second quarter worth $188,902,000. 76.29% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

KMB has been the subject of a number of recent analyst reports. BNP Paribas Exane increased their price target on shares of Kimberly-Clark from $101.00 to $110.00 and gave the company a “neutral” rating in a research note on Friday. Barclays lifted their price objective on shares of Kimberly-Clark from $101.00 to $115.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. Seaport Research Partners upgraded shares of Kimberly-Clark to a “buy” rating in a research note on Tuesday, August 4th. UBS Group upped their target price on shares of Kimberly-Clark from $115.00 to $116.00 and gave the company a “neutral” rating in a report on Wednesday, August 5th. Finally, Piper Sandler cut their target price on shares of Kimberly-Clark from $121.00 to $118.00 and set an “overweight” rating for the company in a research note on Friday, September 11th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Kimberly-Clark currently has an average rating of “Hold” and an average price target of $116.50.

Get Our Latest Research Report on KMB

Key Headlines Impacting Kimberly-Clark

Here are the key news stories impacting Kimberly-Clark this week:

  • Positive Sentiment: Preliminary earnings beat expectations: Kimberly-Clark expects third-quarter adjusted EPS of $1.70, ahead of the $1.58 FactSet consensus. The result was achieved despite lower sales, supporting the view that cost controls and operational improvements are helping protect profitability. Reuters preliminary results article
  • Positive Sentiment: 2026 outlook reaffirmed: Management maintained its full-year financial outlook, including organic sales growth expected to be approximately 100 basis points below weighted-average category growth. The absence of a guidance reduction appears to have reassured investors following the weaker sales environment. Kimberly-Clark preliminary results release
  • Positive Sentiment: Price target increased: BNP Paribas Exane raised its KMB target from $101 to $110 while maintaining a neutral rating. The target implies modest upside from the current trading level, providing some valuation support but not signaling strong conviction. Benzinga price target report
  • Neutral Sentiment: China-related legal issue: Reports indicate China cleared claims involving formamide, potentially reducing a regulatory and litigation overhang. However, the broader commercial impact of the controversy remains uncertain. Reuters China claims article
  • Negative Sentiment: Sales and dividend concerns persist: Kimberly-Clark forecast a third-quarter sales decline following a social-media backlash in China. Separate coverage warned that the company’s long dividend-growth streak is under pressure as profits shrink, despite free cash flow still covering payouts. Wall Street Journal sales outlook article

Kimberly-Clark Stock Performance

Shares of NASDAQ KMB opened at $105.57 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.69 and a debt-to-equity ratio of 3.45. The company has a market capitalization of $35.11 billion, a P/E ratio of 17.95, a P/E/G ratio of 5.39 and a beta of 0.25. Kimberly-Clark Corporation has a 12 month low of $92.42 and a 12 month high of $123.09. The stock has a 50 day moving average of $102.77 and a 200-day moving average of $102.61.

Kimberly-Clark (NASDAQ:KMB – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $1.80 earnings per share for the quarter, missing analysts’ consensus estimates of $2.01 by ($0.21). Kimberly-Clark had a net margin of 11.79% and a return on equity of 143.92%. The business had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $4.22 billion. During the same quarter last year, the company posted $1.92 EPS. The firm’s revenue was up .6% on a year-over-year basis. As a group, equities research analysts predict that Kimberly-Clark Corporation will post 7.33 EPS for the current year.

Kimberly-Clark Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 2nd. Shareholders of record on Friday, September 4th were issued a $1.28 dividend. This represents a $5.12 annualized dividend and a dividend yield of 4.8%. The ex-dividend date was Friday, September 4th. Kimberly-Clark’s payout ratio is currently 87.07%.

Kimberly-Clark Profile

(Free Report)

Kimberly-Clark Corporation (NASDAQ:KMB) is a global personal care and consumer products company that develops and markets essential products for consumers and professional customers. Its portfolio includes products in the baby and childcare, adult care, feminine care, facial and bathroom tissue, and household categories.

The company’s well-known brands include Huggies diapers and wipes, Kleenex tissues, Kotex feminine care products, Cottonelle and Scott bathroom tissue, and Depend and Poise adult care products.

Featured Stories

Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Corporation (NASDAQ:KMB – Free Report).

Institutional Ownership by Quarter for Kimberly-Clark (NASDAQ:KMB)

Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.